These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29916447)

  • 1. Cryotherapy of cutaneous leishmaniasis caused by
    Shaddel M; Sharifi I; Karvar M; Keyhani A; Baziar Z
    J Vector Borne Dis; 2018; 55(1):42-46. PubMed ID: 29916447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone Effects Against Cutaneous Leishmaniasis Caused by
    Azizi H; Mahdavinik E; Hataminejad M; Khamesipour A; Montazeri S
    Infect Disord Drug Targets; 2023; 23(6):e020623217598. PubMed ID: 37278044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.
    van Griensven J; Gadisa E; Aseffa A; Hailu A; Beshah AM; Diro E
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004495. PubMed ID: 26938448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis.
    Mosleh IM; Geith E; Natsheh L; Schönian G; Abotteen N; Kharabsheh S
    J Am Acad Dermatol; 2008 Apr; 58(4):617-24. PubMed ID: 18249466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anti-leishmanial effects of killed Leishmania vaccine with BCG adjuvant in BALB/c mice infected with Leishmania major MRHO/IR/75/ER.
    Nahrevanian H; Jafary SP; Nemati S; Farahmand M; Omidinia E
    Folia Parasitol (Praha); 2013 Feb; 60(1):1-6. PubMed ID: 23539946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.
    Khayeka-Wandabwa C; Kutima H; Nyambati VC; Ingonga J; Oyoo-Okoth E; Karani L; Jumba B; Githuku K; Anjili CO
    Parasit Vectors; 2013 Aug; 6():244. PubMed ID: 23968249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran.
    Mahmoudzadeh-Niknam H; Ajdary S; Riazi-Rad F; Mirzadegan E; Rezaeian A; Khaze V; Djadid ND; Alimohammadian MH
    Trop Med Int Health; 2012 Nov; 17(11):1335-44. PubMed ID: 22947226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
    Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Leishmania gerbilli injection on mice immunization against cutaneous leishmaniasis (CL) caused by Leishmania major.
    Said A; Ali K; Shahrokh I; Hosein H; Mahin M
    Pak J Biol Sci; 2007 Jan; 10(1):196-8. PubMed ID: 19070016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
    Bemani E; Oryan A; Bahrami S
    Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Leishmanization Using
    Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
    Front Immunol; 2020; 11():1725. PubMed ID: 33193290
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
    Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
    Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of host response to Leishmania tropica in mice - different control of skin pathology, chemokine reaction, and invasion into spleen and liver.
    Kobets T; Havelková H; Grekov I; Volkova V; Vojtíšková J; Slapničková M; Kurey I; Sohrabi Y; Svobodová M; Demant P; Lipoldová M
    PLoS Negl Trop Dis; 2012; 6(6):e1667. PubMed ID: 22679519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice.
    Brustolin AÁ; Franzói NM; Ramos-Milaré ÁCFH; Tanoshi CA; Mota CA; Demarchi IG; Lonardoni MVC; Verzignassi Silveira TG
    Exp Parasitol; 2022; 236-237():108259. PubMed ID: 35427563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for Old World cutaneous leishmaniasis.
    Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.
    Calvo-Álvarez E; Guerrero NA; Alvarez-Velilla R; Prada CF; Requena JM; Punzón C; Llamas MÁ; Arévalo FJ; Rivas L; Fresno M; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
    PLoS Negl Trop Dis; 2012; 6(11):e1927. PubMed ID: 23209866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions.
    Özbilgin A; Çulha G; Uzun S; Harman M; Topal SG; Okudan F; Zeyrek F; Gündüz C; Östan İ; Karakuş M; Töz S; Kurt Ö; Akyar I; Erat A; Güngör D; Kayabaşı Ç; Çavuş İ; Bastien P; Pratlong F; Kocagöz T; Özbel Y
    Trop Med Int Health; 2016 Jun; 21(6):783-91. PubMed ID: 27037747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan.
    Larréché S; Launay G; Weibel Galluzzo C; Bousquet A; Eperon G; Pilo JE; Ravel C; Chappuis F; Dupin M; Mérens A
    J Travel Med; 2013; 20(6):400-2. PubMed ID: 24165385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.